🔥 Esophagus & Stomach — Disease
Achalasia's "bird beak" dysphagia and loss of peristalsis trace back to the same inhibitory (NO/VIP) neurons that normally relax the LES, which is covered in Esophagus & Stomach — Normal Function → Esophageal Muscle Transition.
Oral Cavity Disorders
| Condition | Features |
|---|---|
| Aphthous ulcer (canker sore) | Painful, shallow, round ulcer with a yellowish base; recurrent episodes are linked to celiac disease, IBD, Behçet syndrome, and HIV |
| Oral squamous cell carcinoma | Most common oral cavity malignancy, usually on the tongue; risk factors are tobacco, alcohol, and HPV-16; presents as a nonhealing ulcer with raised, irregular edges; leukoplakia (a white patch that can't be scraped off) and erythroplakia (a red patch) are precursor lesions |
Salivary Gland Disorders
| Condition | Mechanism | Features |
|---|---|---|
| Sialolithiasis | Stone obstructs a salivary duct (commonly the submandibular/Wharton duct), often after chronic sialadenitis | Acute pain and swelling, worse with salivation (e.g., citrus stimulation); stone passage can be provoked by sialogogues |
| Sialadenitis | Gland inflammation from obstruction, infection (S. aureus, mumps), or autoimmune disease (e.g., Sjögren syndrome) | Tender, swollen gland; consider Sjögren workup if recurrent/bilateral without an obvious infectious cause |
| Pleomorphic adenoma | Benign mixed-cell tumor, most common salivary neoplasm overall | Slow-growing, painless parotid mass in women 20–40 y/o; recurs if incompletely excised or ruptured intraoperatively; risk of facial nerve injury on resection given its course through the parotid |
| Warthin tumor | Benign cystic tumor with lymphoid (germinal center) tissue, almost always in the parotid | Strongly linked to smoking; can be bilateral or multifocal |
| Mucoepidermoid carcinoma | Mixture of mucus-secreting and squamous cells | Most common malignant salivary tumor; facial nerve involvement or pain suggests malignancy over a benign mass |
Pleomorphic adenoma, Warthin tumor, and mucoepidermoid carcinoma all present as parotid masses, so it's the accompanying clues — pain, rapid growth, facial nerve involvement — that separate malignant (mucoepidermoid) from benign (pleomorphic adenoma, Warthin), not the mass itself.
Esophageal Motility & Structural Disorders
| Condition | Mechanism | Key Features |
|---|---|---|
| Achalasia | Loss of inhibitory (NO/VIP) neurons in the myenteric plexus → failure of LES relaxation + loss of peristalsis | Progressive dysphagia to solids AND liquids; "bird beak" tapering on barium study; manometry shows elevated LES pressure; consider Chagas disease as a secondary cause. Management: calcium channel blockers or nitrates to reduce LES pressure medically; endoscopic botulinum toxin injection for refractory cases; surgical (Heller) myotomy, often paired with a partial fundoplication to limit post-myotomy reflux |
| Diffuse esophageal spasm | Uncoordinated, non-peristaltic contractions | Intermittent chest pain, dysphagia; "corkscrew esophagus" on barium study |
| Zenker diverticulum | False diverticulum above the upper esophageal sphincter (Killian triangle) | Halitosis, regurgitation of undigested food, dysphagia in older adults |
| Mallory-Weiss tear | Mucosal laceration at the gastroesophageal junction from forceful retching | Hematemesis after vomiting; associated with alcohol use, bulimia |
| Boerhaave syndrome | Full-thickness (transmural) esophageal rupture from severe retching | Surgical emergency; subcutaneous emphysema, left pneumothorax, mediastinitis |
| Esophageal varices | Portal hypertension shunts blood into the coronary–azygos venous pathway | Painless, massive hematemesis; risk in cirrhosis |
| Plummer-Vinson syndrome | Triad of dysphagia, iron deficiency anemia, and esophageal webs | Thin, painless webs cause solid-food dysphagia; increased risk of esophageal squamous cell carcinoma; may coexist with glossitis |
| Scleroderma esophageal involvement | Smooth muscle atrophy and fibrosis of the esophageal wall (part of the CREST syndrome spectrum) | ↓ LES pressure and impaired distal motility → severe reflux, dysphagia, stricture, and Barrett metaplasia |
LES tone is the organizing axis for this table: achalasia and diffuse esophageal spasm both come from disordered neural control that raises resistance to bolus passage, while scleroderma does the opposite — smooth muscle fibrosis drops LES tone and causes reflux instead of obstruction.
Esophagitis — Causes by Category
- Reflux (erosive) esophagitis: the most common type, secondary to GERD
- Pill/medication-induced esophagitis: from prolonged mucosal contact with bisphosphonates, tetracyclines, NSAIDs, or iron/potassium supplements — usually prevented by taking pills with plenty of water while upright
- Eosinophilic esophagitis: chronic, immune-mediated eosinophilic infiltration linked to atopic disease (asthma, food allergy); endoscopy shows characteristic rings and linear furrows; presents with dysphagia and food impaction, especially in young patients, and doesn't respond to standard acid suppression alone
- Infectious esophagitis: Candida (white plaques/pseudomembranes, most common), HSV-1 (discrete "punched-out" ulcers), and CMV (larger linear ulcers) — all more common with immunosuppression
- Corrosive esophagitis: from caustic ingestion (acid or alkali), with risk of stricture formation during healing
- All types of esophagitis share the hallmark symptoms of odynophagia (painful swallowing) and/or dysphagia
GERD → Barrett → Adenocarcinoma Progression
- Adenocarcinoma: distal esophagus, arises from Barrett metaplasia, more common in developed countries / white patients
- Squamous cell carcinoma: upper/middle esophagus, linked to alcohol + tobacco, more common in Black patients and in regions with high hot-beverage or nitrosamine exposure
Gastritis & Peptic Ulcer Disease
- Acute (erosive) gastritis
- NSAIDs (↓ prostaglandin-mediated mucosal protection), alcohol, severe physiologic stress
- Curling ulcer: severe burns (↓ mucosal blood flow)
- Cushing ulcer: intracranial injury (↑ vagal stimulation → ↑ acid)
- Chronic gastritis
- Type A (fundal/body): autoimmune, anti-parietal cell antibodies → achlorhydria, B12 deficiency, ↑ gastric cancer risk
- Type B (antral): H. pylori-driven, far more common overall; chronic H. pylori infection also drives MALT lymphoma of the stomach, which can regress with H. pylori eradication alone in early cases
- Ménétrier disease: hyperplasia of the gastric mucosa (fundus/body, sparing the antrum) producing markedly enlarged, wavy rugae; excess mucus secretion leads to protein loss and hypochlorhydria from parietal cell atrophy — presents with weight loss, epigastric pain, and edema from the protein loss; considered a precancerous condition
- Duodenal vs gastric ulcer
| Duodenal ulcer | Gastric ulcer | |
|---|---|---|
| Pain timing | Improves with food | Worsens with food |
| Acid production | Increased | Normal to decreased |
| Malignant potential | Essentially none | Present — biopsy edges |
| H. pylori link | ~90% | ~70% |
Type A and type B chronic gastritis both raise gastric cancer risk, but through different routes — type A's achlorhydria drives chronic hypergastrinemia and ECL hyperplasia, while type B's H. pylori-driven chronic inflammation drives both adenocarcinoma and MALT lymphoma, the latter of which can regress with eradication alone.
- Posterior duodenal ulcers can erode into the gastroduodenal artery, causing brisk, potentially life-threatening hemorrhage; anterior ulcers are more likely to perforate into the peritoneal cavity.
Localizing GI Bleeding — the Ligament of Treitz
- The ligament of Treitz (suspensory ligament of the duodenum) is the anatomic dividing line between upper and lower GI bleeding
- Upper GI bleed (proximal to the ligament): peptic ulcer disease and variceal hemorrhage are the leading causes; presents with hematemesis and/or melena (black, tarry stool — blood has been digested in transit)
- Lower GI bleed (distal to the ligament): diverticulosis, angiodysplasia, hemorrhoids, and colorectal cancer are common causes; presents with hematochezia (bright red or maroon blood, reflecting a shorter transit time)
- Caveat: a brisk upper GI bleed can also present as hematochezia if transit is fast enough, so hemodynamic instability should never be dismissed just because the blood looks "lower GI" in origin
Gastric Neoplasms
- Intestinal-type adenocarcinoma: associated with H. pylori, atrophic gastritis, nitrosamines/smoked foods, blood group A; forms a bulky ulcerating mass
- Diffuse-type (signet ring) adenocarcinoma: infiltrates the gastric wall diffusely → linitis plastica ("leather bottle" stomach); worse prognosis, not clearly H. pylori-linked
- Metastatic spread patterns: Virchow node (left supraclavicular), Krukenberg tumor (bilateral ovarian mets with signet ring cells), Sister Mary Joseph nodule (periumbilical)
- Leiomyoma: most common benign gastric tumor
- Leukoplakia: white mucosal patch that cannot be scraped off; common precursor lesion for oral squamous cell carcinoma
Intestinal-type adenocarcinoma follows a recognizable stepwise pathway from H. pylori-driven inflammation, which is why it's linked to identifiable risk factors and forms a discrete mass; diffuse-type infiltrates independently of that pathway, explaining both its weaker H. pylori association and its worse prognosis.
- Non-selective NSAIDs inhibit both COX-1 (protective gastric mucosal prostaglandins) and COX-2 (inflammation) — this is why they predispose to gastritis and peptic ulcers.
- Selective COX-2 inhibitors (e.g., celecoxib) spare COX-1, reducing GI ulcer risk and — unlike non-selective NSAIDs — do not impair platelet aggregation, since platelet thromboxane synthesis depends on COX-1.
Dumping Syndrome
- Follows gastric surgery (e.g., vagotomy, gastrectomy) that bypasses normal pyloric regulation
- Hyperosmolar chyme dumps rapidly into the small bowel → fluid shifts intraluminally
- Early symptoms: bloating, cramping, diarrhea, tachycardia from volume shift
- Late symptoms (1–3 h): reactive hypoglycemia from an exaggerated insulin surge
🩸 Small & Large Bowel Disorders
Colorectal adenocarcinoma's underlying molecular pathways (adenoma-carcinoma sequence, microsatellite instability, hereditary syndromes) are worked out in much more depth in Colonic Polyps & Polyposis Syndromes → Two Molecular Roads to Colorectal Cancer.
Abdominal Pain Localization Logic
- Visceral peritoneum irritation → dull, poorly localized pain (referred to embryologic dermatome — e.g., early appendicitis = periumbilical)
- Parietal peritoneum irritation → sharp, well-localized pain (e.g., late appendicitis = RLQ / McBurney point)
This visceral-to-parietal progression isn't specific to appendicitis — any inflamed intra-abdominal organ starts as dull, poorly localized pain from visceral peritoneum stimulation and sharpens into localized pain only once inflammation reaches the parietal peritoneum overlying it.
Pain Character as a Diagnostic Clue
- Sharp, boring epigastric pain radiating straight to the back → suggests pancreatitis
- Burning, gnawing epigastric pain → suggests gastric or duodenal ulcer disease
- Pain that begins periumbilically and migrates/localizes to the right lower quadrant → suggests appendicitis
Common Structural & Ischemic Disorders
| Condition | Mechanism | Key Features |
|---|---|---|
| Hiatal hernia | Stomach herniates through the diaphragmatic esophageal hiatus (sliding >> paraesophageal) | Predisposes to GERD; retrosternal discomfort, worse supine |
| Appendicitis | Luminal obstruction (fecalith, lymphoid hyperplasia) → bacterial overgrowth, distention, ischemia | Periumbilical pain migrating to McBurney point; anorexia, low-grade fever, leukocytosis; positive psoas sign (pain with hip extension, suggests a retrocecal appendix), obturator sign (pain with internal rotation of a flexed hip, suggests a pelvic appendix), or Rovsing sign (palpating the left lower quadrant elicits pain in the right lower quadrant); risk of perforation and peritonitis |
| Malrotation ± Ladd bands | Incomplete midgut rotation leaves the cecum in the upper abdomen; abnormal peritoneal (Ladd) bands can form across and compress the duodenum | Presents in infancy with bilious vomiting; predisposes to midgut volvulus, a surgical emergency |
| Diverticulosis | Outpouchings (false diverticula: mucosa/submucosa herniate through the muscularis) at points of vasa recta penetration, low-fiber diet | Usually asymptomatic; most common cause of painless lower GI bleeding |
| Diverticulitis | Obstruction/microperforation of a diverticulum with inflammation | LLQ pain (sigmoid colon), fever, leukocytosis — painful, unlike diverticulosis |
| Acute mesenteric ischemia | Thrombotic, embolic, or low-flow occlusion of mesenteric vessels | Pain out of proportion to exam; "thumbprinting" on imaging; can rapidly progress to infarction |
| Chronic mesenteric ischemia | Atherosclerotic narrowing of two or more mesenteric vessels ("intestinal angina") | Dull postprandial abdominal pain → food aversion and weight loss, similar in logic to cardiac angina |
| Ischemic colitis | Hypoperfusion of watershed zones | Splenic flexure and rectosigmoid junction most vulnerable (double blood supply territory boundary); crampy pain followed by hematochezia |
| Angiodysplasia | Acquired tortuous, thin-walled submucosal vessels, usually right colon | Painless hematochezia in older adults; linked to aortic stenosis and end-stage renal disease |
| Volvulus | Twisting of bowel on its mesentery | Sigmoid volvulus: elderly, constipated patients, "coffee bean" sign; cecal/midgut volvulus: younger patients |
| Intussusception | Telescoping of proximal bowel into distal segment | Classic pediatric cause: "lead point" often idiopathic (lymphoid hyperplasia) or Meckel diverticulum; "currant jelly" stool, sausage-shaped mass |
Acute mesenteric ischemia and ischemic colitis are both ischemic, but differ in speed and severity for anatomic reasons: acute mesenteric ischemia is a true vessel occlusion that outpaces collateral flow, while ischemic colitis strikes watershed zones that only fail when global perfusion drops, which is why it tends to be less catastrophic.
Mechanical vs Functional Obstruction
- Small-bowel obstruction: most often caused by postsurgical adhesions; also hernias, intussusception
- Large-bowel obstruction: most often caused by colorectal neoplasm; also volvulus, severe diverticular stricture
- Gallstone ileus: a gallstone erodes through a cholecystoenteric fistula and mechanically obstructs the bowel, classically at the ileocecal valve — a mechanical obstruction despite the name
- Ileus (adynamic/paralytic): temporary failure of coordinated peristalsis without a mechanical blockage; common postoperatively; distinguished from mechanical obstruction by diffusely decreased bowel sounds and absence of a transition point on imaging
Small- and large-bowel obstruction differ in leading cause largely for anatomic reasons — the small bowel has a large peritoneal surface prone to postsurgical adhesions, while the colon's lumen narrows distally, so an intraluminal mass is more likely to obstruct there than proximally.
Colorectal Adenocarcinoma
- Risk factors: chronic IBD, low-fiber/high-fat diet, hereditary polyposis syndromes, age
- Adenoma-carcinoma sequence: APC mutation → early adenoma → K-RAS mutation → intermediate adenoma → p53 loss → carcinoma
- Right-sided tumors: exophytic growth, occult bleeding → iron-deficiency anemia, fatigue; often present late
- Left-sided tumors: annular "napkin-ring" growth → obstruction, change in bowel habits, visible blood in stool; present earlier
- CEA is useful for monitoring treatment response/recurrence, not for screening or diagnosis
Right- and left-sided colorectal cancers present differently mainly because of luminal caliber and stool consistency — the wide right colon with liquid stool tolerates an exophytic mass silently until it bleeds occultly, while the narrow left colon with solid stool obstructs early around an annular tumor.
Carcinoid Tumor
- Arises from neuroendocrine (enterochromaffin/Kulchitsky) cells; most common site is the appendix
- Secretes serotonin and other vasoactive substances
- Carcinoid syndrome (flushing, diarrhea, bronchospasm, right-sided valvular lesions) occurs only once hepatic metabolism is bypassed — i.e., with liver metastases, since the liver normally clears serotonin from portal blood
- Diagnosis: elevated urinary 5-HIAA (serotonin metabolite)
Functional & Other Inflammatory Bowel Conditions
| Condition | Features |
|---|---|
| Irritable bowel syndrome | Recurrent abdominal pain tied to defecation, with a change in stool frequency or form, in the absence of any structural abnormality; most common in middle-aged women; can be diarrhea-predominant, constipation-predominant, or mixed; often coexists with anxiety, depression, or fibromyalgia; first-line management is dietary and lifestyle modification |
| Microscopic colitis | Chronic watery diarrhea with a grossly normal-appearing colon on endoscopy; diagnosis requires biopsy, which shows a lymphocytic infiltrate or a thickened subepithelial collagen band; most common in older women |
| Necrotizing enterocolitis | Ischemic/infectious necrosis of bowel mucosa in premature, formula-fed infants with an immature gut immune system; classic finding is pneumatosis intestinalis (gas within the bowel wall) on imaging |
| Proctitis | Inflammation limited to the rectal mucosa from infection (gonorrhea, chlamydia, HSV, Shigella), IBD, or radiation; presents with tenesmus, rectal pain, and bleeding |
🔁 Inflammatory Bowel Disease
The drugs used to induce and maintain remission in Crohn disease and UC (5-ASAs, steroids, immunomodulators, anti-TNF agents) are detailed in GI Pharmacology → Antidiarrheals & IBD Therapeutics.
| Feature | Crohn Disease | Ulcerative Colitis |
|---|---|---|
| Location | Mouth to anus, skip lesions; terminal ileum common | Colon and rectum only, continuous, starts distally |
| Depth | Transmural | Mucosal & submucosal only |
| Gross appearance | Cobblestoning, creeping fat, strictures, fistulas | Continuous friable mucosa, pseudopolyps |
| Histology | Noncaseating granulomas | Crypt abscesses |
| Symptoms | Diarrhea (often non-bloody), malabsorption, weight loss | Bloody, mucoid diarrhea |
| Complications | Fistulas, strictures, abscesses, B12 deficiency (terminal ileum involvement) | Toxic megacolon, higher colorectal cancer risk |
| Extraintestinal | Aphthous ulcers, arthritis, erythema nodosum | Primary sclerosing cholangitis (strong link), pyoderma gangrenosum, arthritis |
- Crohn goes deep and skips around; UC stays shallow and stays continuous, starting at the rectum and moving proximally.
Colectomy is curative for ulcerative colitis but not for Crohn disease, precisely because UC's mucosal inflammation stays confined to the colon and rectum while Crohn's transmural disease can recur anywhere from mouth to anus.
🫘 The Hepatobiliary System
Biliary colic and cholecystitis are driven by CCK-mediated gallbladder contraction against an obstructed cystic duct, a mechanism explained in GI Hormones & Neural Control → Major GI Hormones.
Functional Liver Anatomy
- Hepatic lobule: hexagonal unit centered on a central vein, with portal triads (hepatic artery, portal vein, bile duct branch) at the corners
- Zone 1 (periportal): first to receive oxygenated blood — most susceptible to viral hepatitis and toxin-mediated injury requiring bioactivation
- Zone 3 (pericentral): lowest oxygen tension — most susceptible to ischemia and to injury from metabolites generated by cytochrome P450 (e.g., acetaminophen toxicity, alcoholic injury)
- Kupffer cells: resident macrophages lining the sinusoids that clear bacteria and worn-out red blood cells
- Hepatic stellate (Ito) cells: store vitamin A while quiescent; become activated in chronic injury to lay down extracellular matrix — the main driver of hepatic fibrosis
- Acetaminophen (via toxic metabolite, see below)
- Valproic acid
- Halothane and other volatile anesthetics
- Isoniazid, amoxicillin-clavulanate, and statins are additional commonly tested hepatotoxic agents
Zone 1 and zone 3 vulnerability come from different mechanisms — zone 1 is exposed first to whatever arrives in portal blood (viruses, ingested toxins), while zone 3's low oxygen tension and high cytochrome P450 activity make it the site where toxic metabolites like NAPQI accumulate, which is why both acetaminophen and alcohol injury concentrate there.
Bile Acid Synthesis & Enterohepatic Circulation
- Colonic bacteria deconjugate/dehydroxylate a portion of bile salts into secondary bile acids
- ~95% of bile salts are actively reabsorbed at the terminal ileum and recycled to the liver (enterohepatic circulation)
- ~5% are lost in feces daily — this fecal loss is the route by which the body eliminates cholesterol, and it's the target of bile acid-binding resin therapy
- Terminal ileum disease or resection interrupts this cycle → bile salt malabsorption, diarrhea, and impaired fat-soluble vitamin absorption
Bile acid-binding resins and terminal ileum disease both interrupt the same enterohepatic loop but with opposite consequences: resins force the liver to divert more cholesterol into new bile acid synthesis (lowering LDL), while ileal disease simply loses bile salts to the colon, where they act as secretagogues and cause diarrhea.
Acetaminophen (APAP) Hepatotoxicity
- In overdose, glutathione stores are depleted → NAPQI accumulates and covalently binds hepatocyte proteins → centrilobular (zone 3) necrosis
- CYP450 inducers (chronic ethanol use, isoniazid, rifampin, phenytoin, barbiturates, carbamazepine) increase NAPQI generation and worsen toxicity risk
- Antidote: N-acetylcysteine — replenishes glutathione stores and can also directly detoxify NAPQI
- Activated charcoal / gastric decontamination may help if given soon after ingestion
Bilirubin Metabolism & Jaundice
| Predominant Hyperbilirubinemia | Cause | Mechanism |
|---|---|---|
| Unconjugated (indirect) | Hemolysis | Bilirubin overproduction exceeds conjugating capacity |
| Gilbert syndrome | Mildly reduced UGT1A1 activity; benign, stress-triggered mild jaundice | |
| Crigler-Najjar syndrome | Severe/absent UGT1A1 activity; type I is life-threatening (kernicterus risk) | |
| Conjugated (direct) | Dubin-Johnson / Rotor syndrome | Defective hepatocyte excretion of conjugated bilirubin into bile canaliculi |
| Biliary obstruction (stones, stricture, tumor) | Conjugated bilirubin cannot reach the gut → backs up into blood |
- Dubin-Johnson syndrome classically causes a grossly black-appearing liver on gross pathology, despite being a benign, asymptomatic condition.
The whole table reduces to one question — did the defect happen before or after conjugation? Anything upstream (overproduction, impaired uptake, low UGT1A1 activity) backs up lipid-soluble unconjugated bilirubin, while anything downstream (defective excretion, obstruction) backs up water-soluble conjugated bilirubin that can actually appear in urine.
Neonatal Hyperbilirubinemia
- Mild unconjugated hyperbilirubinemia is nearly universal in the first week of life, from a combination of high fetal RBC turnover, an immature (low-activity) UGT1A1 enzyme, and a sterile newborn gut that favors bilirubin reabsorption over excretion — this benign physiologic pattern typically resolves within 1–2 weeks without treatment
- Breastfeeding failure jaundice: insufficient milk intake in the first days of life slows gut transit and bilirubin elimination in stool, increasing enterohepatic recirculation
- Breast milk jaundice: a compound in breast milk increases intestinal deconjugation of bilirubin, appearing later (after the first week) and lasting longer than typical physiologic jaundice
- Severe, poorly controlled unconjugated hyperbilirubinemia risks kernicterus — deposition of lipid-soluble bilirubin in the basal ganglia and brainstem, causing permanent neurologic injury
- Treatment is phototherapy, which converts unconjugated bilirubin into water-soluble photoisomers that can be excreted without needing hepatic conjugation
Liver Enzyme Pattern Interpretation
- AST/ALT disproportionately elevated → hepatocellular injury pattern
- ALP/GGT disproportionately elevated → cholestatic/obstructive pattern
- AST:ALT ratio > 2:1 classically suggests alcoholic liver injury
- Synthetic function: prolonged PT/INR and low albumin indicate advanced hepatic dysfunction (not acute injury alone) — the liver synthesizes albumin and most coagulation factors, so significant hepatocyte loss (roughly >90%) is needed before synthetic capacity clearly declines
- Broad causes of a hepatocellular pattern
- Autoimmune hepatitis
- Viral hepatitis (B, C)
- Drugs/toxins, chronic ethanol use
- Fatty liver disease
- Infiltrative tumors
- Hemodynamic causes (right heart failure, shock liver)
- Iron overload (hemochromatosis) or copper overload (Wilson disease)
- Using GGT to localize an isolated ALP elevation
- ALP is produced by both liver/biliary tissue and bone (and placenta in pregnancy)
- GGT is essentially liver/biliary-specific
- Elevated ALP + elevated GGT → hepatobiliary source
- Elevated ALP + normal GGT → consider bone disease or pregnancy instead
GGT plays the same role here that a confirmatory test plays elsewhere: ALP alone is ambiguous because bone, placenta, and liver all produce it, so pairing it with the liver-specific GGT is what actually localizes an isolated ALP rise to the hepatobiliary system.
Viral Hepatitis
| Hep A | Hep B | Hep C | Hep D | Hep E | |
|---|---|---|---|---|---|
| Genome | ssRNA | dsDNA | ssRNA | Defective ssRNA (needs HBV) | ssRNA |
| Transmission | Fecal-oral | Blood/sexual/vertical | Blood-borne (transfusion historically) | Blood/sexual (co- or superinfection with HBV) | Fecal-oral |
| Chronicity | No | Possible (higher risk if acquired perinatally) | Common (majority progress to chronic) | Tied to HBV chronicity | No (except pregnant patients — high mortality risk) |
| HCC risk | No | Yes | Yes | No independent increase | No |
- HBsAg positive = active infection (acute or chronic)
- Anti-HBs positive = immunity (recovery or vaccination)
- Anti-HBc IgM = recent/acute infection; IgG = past or chronic infection
- "Window period": HBsAg has cleared but anti-HBs has not yet appeared — anti-HBc IgM is the only positive marker
Cirrhosis — Common Causes & Signature Findings
| Etiology | Distinguishing Lab/Path Finding | Notes |
|---|---|---|
| Chronic alcohol use | AST:ALT > 2:1; micronodular fibrosis | Most common cause of cirrhosis overall (developed countries) |
| Chronic viral hepatitis (B/C) | Positive viral serologies | Leading cause of cirrhosis progressing to HCC |
| Wilson disease | ↓ ceruloplasmin, ↑ urinary copper | Copper deposits in liver, basal ganglia (movement disorders), cornea (Kayser-Fleischer rings); treated with copper chelation (penicillamine or trientine) |
| Hereditary hemochromatosis | ↑ ferritin, ↑ transferrin saturation, ↓ TIBC | Iron deposits in liver, pancreas (diabetes), skin (bronze pigmentation), heart; treated with therapeutic phlebotomy or iron chelation (deferoxamine/deferasirox) if phlebotomy isn't tolerated |
| Alpha-1 antitrypsin deficiency | ↓ serum A1AT | Misfolded protein accumulates in hepatocytes → liver disease; also causes panacinar emphysema |
| Primary biliary cholangitis | Positive antimitochondrial antibody | Autoimmune destruction of intrahepatic bile ducts; middle-aged women; first-line treatment is ursodiol |
| Primary sclerosing cholangitis | "Beading" of intra/extrahepatic ducts on cholangiography | Strong association with ulcerative colitis; ↑ cholangiocarcinoma risk |
| Chronic passive venous congestion | Right heart failure or constrictive pericarditis → hepatic sinusoidal congestion | "Nutmeg liver" gross appearance; can progress to cardiac cirrhosis if longstanding |
This table sorts into two mechanistic families: metal-overload diseases (Wilson, hemochromatosis) and AAT deficiency all cause cirrhosis through pathologic accumulation of something the liver can't clear, while PBC and PSC both cause it through immune-mediated bile duct destruction that differs mainly by duct location and disease association.
Alcohol-Associated (and Metabolic) Liver Disease Spectrum
- Driven by excess NADH generation during alcohol metabolism, which favors fat synthesis and impairs fatty acid oxidation
- Mallory bodies are damaged, eosinophilic intracytoplasmic keratin clumps seen in steatohepatitis, whether from alcohol or metabolic disease
- Metabolic dysfunction–associated steatotic liver disease (MASLD, formerly "NAFLD") is the metabolic-syndrome counterpart — obesity-driven hepatic fat accumulation without significant alcohol use; its inflammatory stage (MASH, formerly NASH) can progress to cirrhosis and hepatocellular carcinoma through the same steatosis → steatohepatitis → fibrosis sequence
Reye Syndrome
- Rare, potentially fatal pediatric hepatic encephalopathy triggered by giving aspirin during a viral illness (classically varicella or influenza)
- Aspirin metabolites reversibly inhibit mitochondrial enzymes → impaired beta-oxidation → microvesicular fatty liver, hyperammonemia, hypoglycemia, and progressive encephalopathy with cerebral edema
- This is why aspirin is avoided in children except for specific indications like Kawasaki disease
Consequences of Portal Hypertension
- Splenomegaly, ascites, hepatic encephalopathy (impaired ammonia clearance)
- Rising portal pressure forces blood through small collateral veins that normally connect the portal and systemic circulations — these collaterals dilate into varices at three classic sites:
| Site | Anastomosis (portal ↔ systemic) | Clinical sign |
|---|---|---|
| Esophagus | Left gastric vein ↔ esophageal veins (drain to azygos) | Esophageal varices — risk of massive hematemesis |
| Umbilicus | Paraumbilical vein ↔ superficial epigastric veins of the abdominal wall | Caput medusae |
| Rectum | Superior rectal vein ↔ middle/inferior rectal veins | Anorectal (internal hemorrhoidal) varices |
- TIPS (transjugular intrahepatic portosystemic shunt) creates a direct channel between the portal vein and a hepatic vein to decompress portal pressure — effective for refractory varices/ascites, but by diverting blood around the liver's filtering capacity it can precipitate or worsen hepatic encephalopathy
All three varix sites are just fetal or normally-quiescent portosystemic channels forced open by rising pressure, which is also why TIPS — a shunt that decompresses the portal system directly through the liver — treats the varices but risks worsening encephalopathy by rerouting portal blood around the liver's detoxifying function.
Systemic Manifestations of Cirrhosis
- Neurologic: hepatic encephalopathy (confusion, asterixis — a "flapping tremor" on wrist extension); fetor hepaticus (sweet, musty breath odor from circulating mercaptans)
- Endocrine/skin: gynecomastia, testicular atrophy, spider angiomata, palmar erythema — all reflect impaired hepatic estrogen clearance
- Hematologic: thrombocytopenia and coagulopathy from splenic sequestration (splenomegaly) plus reduced hepatic synthesis of clotting factors
- Renal: hepatorenal syndrome — progressive kidney failure driven by splanchnic vasodilation and reduced effective renal blood flow, without an intrinsic structural kidney lesion; a diagnosis of exclusion in advanced cirrhosis
- Metabolic: hyperbilirubinemia (jaundice), hyponatremia
- Cardiovascular: peripheral edema, hyperdynamic circulation
Spontaneous Bacterial Peritonitis & Vascular Liver Emergencies
- Spontaneous bacterial peritonitis (SBP): infection of ascitic fluid without an obvious surgical source, seen in cirrhotic patients; often subtle (fever, abdominal pain, worsening encephalopathy) or even silent; diagnosed by paracentesis showing an ascitic fluid neutrophil count above roughly 250 cells/mm³; typically caused by gram-negative enteric organisms; treated empirically with a third-generation cephalosporin
- Budd-Chiari syndrome: thrombotic or compressive obstruction of hepatic venous outflow → painful hepatomegaly, ascites, and a mottled "nutmeg liver" from centrilobular congestion; linked to hypercoagulable states, polycythemia vera, and pregnancy; classically spares jugular venous pressure (no JVD), which helps distinguish it from right heart failure as a cause of congestive hepatomegaly
- Portal vein thrombosis: often clinically silent, but can cause portal hypertension, abdominal pain, and fever; risk factors include cirrhosis, malignancy, and pancreatitis
Focal Liver Lesions
- Hepatocellular adenoma: benign; associated with oral contraceptive/anabolic steroid use; risk of rupture and hemorrhage; regresses with cessation of hormone exposure
- Hepatocellular carcinoma: risk factors include cirrhosis (any cause), chronic HBV/HCV, aflatoxin exposure; elevated alpha-fetoprotein; spreads hematogenously
- Cholangiocarcinoma: malignancy of the bile duct epithelium, most often at the confluence of the right and left hepatic ducts; risk factors include primary sclerosing cholangitis and liver fluke infection (Clonorchis); presents late with jaundice and weight loss
- Metastatic disease is the most common cause of a liver mass overall — much more common than primary liver cancer
Cell of origin and tumor marker travel together here: hepatocellular carcinoma arises from hepatocytes and raises AFP, cholangiocarcinoma arises from bile duct epithelium and doesn't, and hepatocellular adenoma is benign and hormone-driven — regressing when the hormonal trigger is removed rather than needing resection outright.
Gallbladder & Biliary Tract Disease
| Condition | Findings |
|---|---|
| Biliary colic | Transient cystic duct obstruction by a stone; postprandial RUQ pain, resolves as stone dislodges |
| Acute cholecystitis | Persistent cystic duct obstruction with inflammation; positive Murphy sign, fever, leukocytosis; a HIDA scan that fails to visualize the gallbladder confirms cystic duct obstruction when ultrasound is equivocal |
| Acalculous cholecystitis | Gallbladder inflammation from stasis or ischemia without stones, typically in critically ill or postoperative patients — same presentation as calculous disease but higher risk of gangrene/perforation |
| Choledocholithiasis | Stone lodged in the common bile duct; obstructive jaundice |
| Acute cholangitis | Infection of an obstructed biliary tree; Charcot triad (fever, jaundice, RUQ pain); Reynolds pentad adds hypotension + altered mental status (suppurative cholangitis) |
| Porcelain gallbladder | Calcified gallbladder wall from chronic cholecystitis, often an incidental imaging finding; prophylactic cholecystectomy is generally recommended given the associated gallbladder cancer risk |
| Gallbladder adenocarcinoma | Courvoisier sign — painlessly palpable, enlarged gallbladder with obstructive jaundice (distinguishes malignant obstruction from stone-related obstruction, which causes a fibrotic, non-distensible gallbladder) |
- Uncomplicated cholelithiasis and acute cholecystitis are managed surgically with cholecystectomy
- Choledocholithiasis and cholangitis are typically managed with endoscopic retrograde cholangiopancreatography (ERCP) to clear the duct; surgical common bile duct exploration is reserved for ERCP failure
Gallstone Composition
- Cholesterol stones: the majority of stones; risk factors include obesity, rapid weight loss, estrogen exposure (pregnancy/OCPs), age, female sex — classic "female, fertile, forty, fat" risk profile
- Pigment stones: form from excess bilirubin, seen with chronic hemolysis (e.g., sickle cell disease, hereditary spherocytosis) or biliary infection; pigment stones in a child or young adult without a hemolytic or infectious cause should raise suspicion for an underlying hemoglobinopathy
🍽️ Esophagus & Stomach — Normal Function
Esophageal Muscle Transition
- Upper esophageal sphincter: skeletal muscle, voluntary control of swallow initiation
- Lower esophageal sphincter (LES): smooth muscle, relaxes via vagal/NO/VIP signaling to admit the bolus, then contracts to prevent reflux
Gastric Motor Function
- Receptive relaxation: vagally-mediated fundic relaxation that accommodates incoming food without a large pressure rise
- Trituration: antral peristaltic waves (~3 per minute) grind food into chyme
- Migrating motor complex (MMC): motilin-driven "housekeeping" contractions that sweep undigested debris through the gut during fasting
Digestion of Proteins in the Stomach
- Intrinsic factor (parietal cells) binds dietary B12 in the stomach → complex travels to terminal ileum for active absorption.
- Loss of parietal cells (e.g., autoimmune gastritis) removes both acid and intrinsic factor → pernicious anemia risk.
Categories of Vomiting Triggers
- Vestibular/labyrinthine disturbance (motion sickness, vertigo)
- Vagally-mediated visceral stimulation (obstruction, distention)
- Opioid and other drug exposure (direct chemoreceptor trigger zone stimulation)
- Migraine
- Metabolic derangement (diabetic ketoacidosis, gastroparesis, hypercalcemia, uremia)
- Infection (gastroenteritis, systemic illness)
- Toxin exposure
- Increased intracranial pressure and alcohol intoxication
- Neurogenic/psychogenic causes
- Pregnancy
- Most of these triggers converge on the chemoreceptor trigger zone (area postrema), a brainstem region outside the blood-brain barrier that senses circulating toxins/drugs and relays to the vomiting center.
⚗️ GI Hormones & Neural Control
Major GI Hormones — Source, Trigger, Action
| Hormone | Source | Stimulus | Key Action(s) |
|---|---|---|---|
| Gastrin | G cells, antrum | Luminal peptides/amino acids, vagal input, distention | ↑ parietal cell H⁺ secretion; trophic to gastric mucosa |
| Cholecystokinin (CCK) | I cells, duodenum/jejunum | Fatty acids, amino acids in lumen | Gallbladder contraction; pancreatic enzyme + HCO₃⁻ release; ↓ gastric emptying; ↑ sphincter of Oddi relaxation |
| Secretin | S cells, duodenum | Luminal acid (H⁺), fatty acids | ↑ pancreatic HCO₃⁻ secretion; ↓ gastric acid secretion; ↓ gastric emptying |
| Gastric inhibitory peptide (GIP) | K cells, duodenum/jejunum | Fatty acids, amino acids, oral glucose | ↑ insulin release (incretin effect); ↓ gastric H⁺ secretion |
| Motilin | Small intestine | Fasting state (cyclic release) | Drives migrating motor complexes (interdigestive housekeeping contractions) |
| Somatostatin | D cells (stomach, duodenum, pancreatic islets) | Acid in lumen | Global inhibitor — ↓ gastrin, ↓ acid, ↓ pancreatic/biliary secretion, ↓ motility |
| VIP | Enteric neurons | Neural reflexes | Smooth muscle + sphincter relaxation (incl. LES); ↑ intestinal secretion |
| Peptide YY | Endocrine cells, ileum & colon | Presence of luminal fat/nutrients reaching the distal gut ("ileal brake") | ↓ gastric acid secretion, slows upper GI motility |
| Nitric oxide | Enteric neurons | Neural reflexes | Smooth muscle relaxation, including the LES |
| Glucagon | Alpha cells, pancreatic islets | Hypoglycemia | Promotes hepatic glycogenolysis and gluconeogenesis |
Most of this table splits into two opposing teams: gastrin, CCK, and motilin promote digestion and motility, while secretin, GIP, somatostatin, and peptide YY brake it — digestion is really a running negotiation between stimulatory hormones triggered by nutrients arriving and inhibitory hormones triggered by nutrients already processed downstream.
Autonomic Modulation of the Gut
- Parasympathetic (vagal, ACh)
- ↑ secretion (salivary, gastric, pancreatic)
- ↑ motility, relaxes sphincters appropriately for transit
- Mediates receptive relaxation of the stomach
- Sympathetic (NE)
- ↓ motility and secretion (redirects blood flow away from gut in "fight-or-flight")
- Contracts sphincters
Three Phases of Gastric Acid Secretion
- Parietal cells (fundus/body) → HCl + intrinsic factor
- Chief cells → pepsinogen (activated to pepsin at low pH)
- G cells (antrum) → gastrin
- Enterochromaffin-like (ECL) cells → histamine, released in response to both gastrin and vagal (ACh) input
- Mucous neck cells → protective bicarbonate-rich mucus
- Gastrin's main effect on acid output is indirect — it stimulates ECL cells to release histamine, which then acts on parietal cell H2 receptors as the dominant final trigger for acid secretion. This is why blocking the H2 receptor blunts acid output from essentially all three stimuli (gastrin, histamine, and vagal ACh) acting in concert, not just histamine alone.
🧪 Digestion, Absorption & Nutrient Handling
Macronutrient Digestion Pathways
- Carbohydrates
- Salivary + pancreatic amylase break starch into disaccharides
- Brush-border enzymes (lactase, sucrase-isomaltase) finish digestion to monosaccharides
- Glucose/galactose: SGLT1 (Na⁺-dependent) transport
- Fructose: GLUT5 facilitated diffusion
- Protein
- Pepsin begins breakdown in stomach
- Pancreatic trypsinogen → trypsin (activated by brush-border enterokinase, then autocatalytic)
- Trypsin activates the rest of the pancreatic zymogen cascade (chymotrypsinogen, proelastase, procarboxypeptidase)
- Absorbed as free amino acids and di-/tripeptides via distinct Na⁺-dependent carriers
- Fat
- Mechanical emulsification in stomach → smaller droplets
- Pancreatic lipase hydrolyzes triglycerides to free fatty acids + monoacylglycerol
- Bile salts (amphipathic) package products into micelles for delivery to the enterocyte brush border
- Inside enterocytes, re-esterified triglycerides + cholesterol + apolipoproteins assemble into chylomicrons → lymphatics (lacteals) → thoracic duct → systemic circulation (bypasses portal vein)
All three macronutrient pathways depend on an activation cascade rather than acting immediately in active form — pepsinogen needs acid, trypsinogen needs enterokinase, and pancreatic lipase needs bile salts for delivery — which is exactly why premature activation of this same trypsinogen cascade inside the pancreas, rather than the duodenum, is what causes pancreatitis.
- Short- and medium-chain fatty acids are absorbed directly into the portal vein (no chylomicron packaging needed) — unlike long-chain fatty acids.
Site-Specific Absorption Map
| Site | Primary Absorbed Substances |
|---|---|
| Duodenum | Iron, calcium, magnesium, folate, fat-soluble vitamins (A, D, E, K) |
| Jejunum | Bulk of carbohydrates, proteins, and fats (majority of nutrient absorption) |
| Ileum | Vitamin B12–intrinsic factor complex, bile salts (enterohepatic recycling); functional reserve capacity |
| Colon | Water and electrolytes (Na⁺ absorbed, K⁺ secreted); short-chain fatty acids from fiber fermentation |
- The colon can absorb roughly 2–3 L of water per day; once this daily capacity is exceeded, the excess is excreted as diarrhea
- The stomach itself absorbs very little of anything except a small amount of ethanol and water
- Defecation is coordinated by both an involuntary rectosphincteric reflex (internal anal sphincter relaxation with rectal distention) and voluntary control of the external anal sphincter
This map predicts disease consequences by location: proximal small bowel disease (celiac) tends to cause iron, calcium, and fat-soluble vitamin deficiency, while terminal ileum disease (Crohn, resection) selectively causes B12 deficiency and bile salt malabsorption, since the ileum is the only site handling either.
Lipoprotein Trafficking Overview
- High LDL is an independent risk factor for atherosclerosis and coronary artery disease
- Statins (HMG-CoA reductase inhibitors) are first-line for lowering LDL; monitor liver enzymes for hepatotoxicity
- Bile acid-binding resins (cholestyramine, colestipol) bind intestinal bile acids and prevent their reabsorption, forcing the liver to divert more cholesterol into new bile acid synthesis — net effect is lowered LDL
- Niacin (nicotinic acid) suppresses hepatic release of VLDL, secondarily lowering LDL and raising HDL; flushing is a common side effect
🦠 Infectious & Mechanistic Diarrhea
Osmotic and secretory diarrhea both come down to overwhelming the colon's normal water-handling capacity, which is quantified in Digestion, Absorption & Nutrient Handling → Site-Specific Absorption Map.
Diarrhea Mechanisms
- Osmotic: unabsorbed solutes pull water into the lumen (e.g., lactase deficiency); resolves with fasting
- Secretory: active ion (Cl⁻) secretion drives obligatory water loss (e.g., cholera toxin); persists with fasting
- Inflammatory/exudative: mucosal damage causes protein/blood/pus leakage into lumen (e.g., invasive bacteria, IBD)
- Motility-related: altered transit time (e.g., IBS, hyperthyroidism, diabetic autonomic neuropathy)
Bacterial Causes
| Organism | Stool Pattern | Distinguishing Notes |
|---|---|---|
| Vibrio cholerae | Watery, "rice water" stool | Toxin activates adenylate cyclase → ↑cAMP → Cl⁻ secretion; classic secretory diarrhea |
| Enterotoxigenic E. coli (ETEC) | Watery | Most common cause of traveler's diarrhea; heat-labile/heat-stable toxins |
| Enterohemorrhagic E. coli (O157:H7) | Bloody | Shiga-like toxin; undercooked beef; risk of hemolytic uremic syndrome — avoid antibiotics (↑ toxin release) |
| Salmonella (non-typhoidal) | Bloody or watery | Poultry, eggs, reptiles; invades but does not usually require antibiotics; a relatively high inoculum (~100,000 organisms) is typically needed to cause infection |
| Shigella | Bloody, mucoid | Very low infectious dose (~10–100 organisms); Shiga toxin; may cause reactive arthritis, HUS |
| Campylobacter jejuni | Bloody | Leading bacterial cause of food-borne diarrhea in the US; associated with Guillain-Barré syndrome |
| Clostridioides difficile | Watery, foul-smelling | Antibiotic-associated; pseudomembranous colitis; treat with oral vancomycin or fidaxomicin |
| Yersinia enterocolitica | Bloody | Can mimic appendicitis (mesenteric adenitis); contaminated pork/dairy |
Infectious dose is doing real epidemiologic work in this table — Shigella's tiny inoculum (~10–100 organisms) supports person-to-person and fecal-oral spread even with minimal contamination, while Salmonella's much higher required dose (~100,000) means it usually needs food that's actively supported bacterial growth.
Viral & Protozoal Causes
| Organism | Population/Setting | Notes |
|---|---|---|
| Rotavirus | Infants/young children | Most common cause of severe pediatric diarrhea worldwide; vaccine-preventable |
| Norovirus | All ages, outbreaks (cruise ships, schools) | Highly contagious, short incubation |
| Giardia lamblia | Campers, contaminated water | Foul-smelling, greasy stool (malabsorptive); trophozoite has a characteristic "face" appearance; treat with metronidazole |
| Entamoeba histolytica | Endemic/travel exposure | Flask-shaped ulcers, bloody dysentery, risk of liver abscess ("anchovy paste") |
| Cryptosporidium | Immunocompromised (esp. AIDS) | Severe watery diarrhea; self-limited if immunocompetent |
🧫 GI Pathogens — Quick Reference
This is a quick-reference list; the clinical presentations, stool patterns, and distinguishing features for these same organisms are covered in Infectious & Mechanistic Diarrhea → Bacterial Causes.
Bacterial
- Salmonella, Shigella
- Escherichia coli (ETEC, EHEC, EIEC, EPEC subtypes)
- Campylobacter jejuni
- Vibrio cholerae
- Clostridioides difficile
- Yersinia enterocolitica
- Staphylococcus aureus (preformed toxin, rapid-onset food poisoning)
- Bacillus cereus (fried rice-associated)
- Helicobacter pylori
Parasitic
- Entamoeba histolytica
- Giardia lamblia
- Cryptosporidium
- Ascaris lumbricoides
- Strongyloides stercoralis
- Trichuris trichiura
Viral
- Rotavirus
- Norovirus
- Adenovirus (enteric serotypes)
🥞 The Pancreas
Acute pancreatitis is fundamentally the premature activation of the same trypsinogen → trypsin cascade that normally drives protein digestion, detailed in Digestion, Absorption & Nutrient Handling → Macronutrient Digestion Pathways.
Acute vs Chronic Pancreatitis
| Acute Pancreatitis | Chronic Pancreatitis | |
|---|---|---|
| Top causes | Gallstones, alcohol ("GET SMASHED": Gallstones, Ethanol, Trauma, Steroids, Mumps, Autoimmune, Scorpion sting, Hyperlipidemia/Hypercalcemia, ERCP, Drugs) | Chronic alcohol use (adults); cystic fibrosis (children) |
| Mechanism | Premature intrapancreatic activation of trypsinogen → autodigestion | Recurrent injury → fibrosis, calcification, loss of exocrine/endocrine tissue |
| Presentation | Severe epigastric pain radiating to the back, nausea/vomiting; Cullen sign (periumbilical) or Grey Turner sign (flank) with hemorrhagic necrosis | Steatorrhea, diabetes, chronic epigastric pain, weight loss |
| Labs/imaging | ↑ lipase (more specific), ↑ amylase; hypocalcemia (saponification) | Pancreatic calcifications on imaging; enzymes may be normal in burnt-out disease |
| Complications | Pseudocyst, necrosis, abscess, ARDS, shock | Malabsorption, diabetes mellitus, ↑ pancreatic cancer risk |
- Amylase/lipase elevations tend to be markedly higher (often in the thousands) in gallstone-induced pancreatitis compared with a more modest rise (often in the hundreds) in alcohol-induced pancreatitis, since chronic alcohol use progressively reduces functioning acinar tissue available to release enzyme.
Pancreatic Exocrine Neoplasm
- Ductal adenocarcinoma
- Risk factors: smoking, chronic pancreatitis, age, diabetes
- Over half arise in the pancreatic head → obstructive jaundice (often painless)
- Trousseau sign (migratory superficial thrombophlebitis) is a classic paraneoplastic clue
- Elevated CA 19-9 (tumor marker); poor overall prognosis due to late presentation
Painless jaundice is a location clue, not a stage clue — most ductal adenocarcinomas arise in the pancreatic head specifically because that's where the tumor mechanically obstructs the adjacent common bile duct, not because head tumors are inherently more advanced than body or tail tumors.
Pancreatic Endocrine (Islet Cell) Tumors
| Tumor | Cell of Origin | Presentation |
|---|---|---|
| Insulinoma | Beta cells | Whipple triad: fasting hypoglycemia, CNS symptoms, relief with glucose; elevated C-peptide distinguishes it from exogenous insulin use |
| Gastrinoma (Zollinger-Ellison syndrome) | Gastrin-secreting cells (pancreas or duodenum) | Recurrent/refractory peptic ulcers, often distal or multiple; may be part of MEN 1 |
- Multiple endocrine neoplasia type 1 involves the "3 P's": Pituitary, Parathyroid, and Pancreas tumors.
🔴 Colonic Polyps & Polyposis Syndromes
Chronic ulcerative colitis raises colorectal cancer risk through a distinct route — longstanding mucosal inflammation and dysplasia rather than the adenoma-carcinoma sequence — as noted in Inflammatory Bowel Disease.
Nonneoplastic Polyps
- These lack significant malignant potential on their own — worth recognizing so they aren't confused with the neoplastic types below
| Type | Notes |
|---|---|
| Hyperplastic polyp | Most common polyp type overall; small, usually in the rectosigmoid; occasionally evolves toward a serrated lesion |
| Inflammatory pseudopolyp | Islands of regenerating mucosa surrounded by ulceration in IBD, not a true growth |
| Mucosal polyp | Tiny (<5 mm), resembles normal mucosa, clinically insignificant |
| Submucosal polyp | Lipoma, leiomyoma, or similar non-epithelial growth bulging into the lumen |
Neoplastic Polyp Types (by malignant potential)
- Villous adenomas tend to be sessile (flat-based) with fingerlike projections and carry the greatest malignant potential
- Tubular adenomas are the most common polyp type overall and are usually pedunculated
- Larger size and higher villous component both increase cancer risk
- Serrated polyps are a separate neoplastic pathway (distinct from the tubular/tubulovillous/villous adenoma spectrum) — they carry a "saw-tooth" crypt pattern on biopsy and silence mismatch repair genes through promoter methylation, feeding into the same microsatellite instability route discussed below
Villous adenomas carry more cancer risk than tubular ones largely for structural reasons — their broad, sessile base exposes more epithelial surface to luminal carcinogens, while a tubular adenoma's stalk both limits that exposure and makes complete removal easier.
Hereditary Polyposis Syndromes
| Syndrome | Genetics | Key Features |
|---|---|---|
| Familial adenomatous polyposis (FAP) | APC mutation, autosomal dominant | Hundreds to thousands of colonic polyps; near-100% cancer risk without colectomy |
| Gardner syndrome | APC mutation variant | FAP + osteomas, soft tissue tumors, dental abnormalities |
| Turcot syndrome | APC mutation variant | FAP/Lynch-type polyposis + CNS tumors (medulloblastoma, glioblastoma) |
| Peutz-Jeghers syndrome | STK11 mutation, autosomal dominant | Benign hamartomatous polyps; mucocutaneous hyperpigmentation (lips, palms); increased risk of GI and other organ cancers despite polyps being benign |
| Lynch syndrome (HNPCC) | DNA mismatch repair gene mutation, autosomal dominant | Fewer polyps but early-onset, right-sided colorectal cancer; also endometrial, ovarian, and skin cancer risk |
| Juvenile polyposis syndrome | Autosomal dominant, typically presents before age 5 | Numerous hamartomatous polyps in the colon, stomach, and small bowel; increased colorectal cancer risk despite the polyps themselves being hamartomas |
| MUTYH-associated polyposis | MUTYH DNA-repair gene, autosomal recessive | Adenomatous (and sometimes serrated) polyps with markedly increased colorectal cancer risk; also linked to duodenal, ovarian, and bladder tumors |
Polyp count and cancer risk aren't the same axis — FAP-family syndromes generate hundreds to thousands of polyps with near-certain progression given enough time, while Lynch syndrome generates relatively few polyps that progress unusually fast, which is why screening intervals for Lynch are shorter despite the lower polyp burden.
Two Molecular Roads to Colorectal Cancer
- Chromosomal instability pathway: APC loss → RAS mutation → p53 loss (the classic adenoma-carcinoma sequence); underlies FAP and most sporadic, typically left-sided cancers
- Microsatellite instability pathway: mismatch repair gene loss or silencing (e.g., MLH1) via the serrated polyp route; underlies Lynch syndrome and a subset of sporadic, typically right-sided cancers
Screening & Diagnostic Pearls
- Average-risk screening starts at age 45 with colonoscopy (or an alternative such as fecal immunochemical testing, FIT-DNA, or CT colonography)
- A first-degree relative with colon cancer moves screening up to age 40, or 10 years before that relative's age at diagnosis, whichever is earlier
- Patients with longstanding IBD begin screening about 8 years after disease onset
- An "apple core" napkin-ring lesion on barium enema reflects an annular, obstructing left-sided tumor
- Streptococcus gallolyticus (formerly S. bovis) bacteremia or endocarditis is a classic clue prompting a colonoscopy to look for an underlying colorectal tumor
- CEA is used to monitor for recurrence after treatment, not as a screening test
📉 Malabsorption Syndromes
These syndromes disrupt specific steps of normal nutrient handling — brush-border enzymes, site-specific absorption, or mucosal architecture — laid out in Digestion, Absorption & Nutrient Handling → Site-Specific Absorption Map.
| Condition | Mechanism | Key Features |
|---|---|---|
| Celiac disease | Immune reaction to gluten (gliadin) → villous blunting, crypt hyperplasia | Associated with HLA-DQ2/DQ8; anti-tTG and anti-endomysial antibodies; improves on gluten-free diet; ↑ risk of enteropathy-associated T-cell lymphoma |
| Tropical sprue | Presumed infectious insult damaging small bowel mucosa | Occurs in tropical regions; responds to antibiotics, unlike celiac disease |
| Whipple disease | Systemic infection with Tropheryma whippelii; PAS-positive foamy macrophages infiltrate lamina propria | Older male patients; diarrhea, arthralgia, lymphadenopathy, weight loss, CNS involvement possible |
| Disaccharidase deficiency | Lactase (most common) or other brush-border enzyme deficiency | Bloating, osmotic diarrhea after dairy; normal-appearing mucosa; hydrogen breath test |
| Abetalipoproteinemia | Defective apolipoprotein B synthesis → chylomicrons and VLDL cannot form | Autosomal recessive; fat malabsorption, acanthocytes, ataxia, retinitis pigmentosa in childhood |
| Small intestinal bacterial overgrowth | Excess colonic-type bacteria in small bowel (stasis, motility disorders) | Bloating, diarrhea, B12 deficiency (bacteria consume B12); folate may be normal/increased (bacterial synthesis) |
| Chronic pancreatitis / exocrine insufficiency | Loss of pancreatic lipase | Steatorrhea, fat-soluble vitamin deficiency |
| Short bowel syndrome | Inadequate small bowel surface area after major resection (e.g., for Crohn disease, mesenteric ischemia, trauma) | Voluminous postprandial diarrhea, dehydration, weight loss; loss of the terminal ileum specifically causes bile salt malabsorption, steatorrhea, and increased calcium oxalate kidney stone risk |
- D-xylose is a simple sugar absorbed passively in the proximal small bowel without needing pancreatic enzymes
- Abnormal (low) blood/urine levels → points to a mucosal problem (e.g., celiac disease, tropical sprue)
- Normal levels despite steatorrhea → points to pancreatic exocrine insufficiency, since the mucosa itself is intact
- Fat malabsorption of any cause can cascade into deficiencies of vitamins A, D, E, and K — think night blindness, osteomalacia, neuropathy, and coagulopathy respectively.
💊 GI Pharmacology
Octreotide's role in acute variceal bleeding follows from the portal hypertension it's treating — splanchnic vasodilation forcing blood through esophageal collaterals — explained in The Hepatobiliary System → Consequences of Portal Hypertension.
Acid-Suppressing & Mucosal-Protective Agents
| Class / Drug | Mechanism | Notable Adverse Effects |
|---|---|---|
| Proton pump inhibitors (omeprazole, esomeprazole) | Irreversibly inhibit H⁺/K⁺-ATPase in parietal cells | Increased fracture risk with long-term use, B12/magnesium deficiency, rebound hyperacidity, C. difficile risk |
| H2 blockers (famotidine, cimetidine) | Reversibly block histamine H2 receptors on parietal cells | Cimetidine: potent CYP450 inhibitor, antiandrogen effects (gynecomastia), also reduces renal creatinine excretion (can falsely elevate serum creatinine); famotidine has fewer interactions |
| Antacids (Al(OH)3, Mg(OH)2, CaCO3) | Directly neutralize gastric acid | Aluminum → constipation; magnesium → diarrhea; calcium → constipation/hypercalcemia; all can alter absorption of other drugs |
| Sucralfate | Binds to ulcer base, forms protective barrier | Requires acidic environment to activate; can impair absorption of other drugs |
| Misoprostol | PGE1 analog — restores protective mucus/bicarbonate, ↓ acid | Contraindicated in pregnancy (abortifacient/uterotonic) |
| Bismuth subsalicylate | Coats ulcers, antimicrobial properties | Used in H. pylori quadruple therapy; harmless black stool/tongue |
| Muscarinic antagonists (pirenzepine, propantheline) | Block M1 receptors on ECL cells and M3 receptors on parietal cells → ↓ histamine and acid secretion | Rarely used now; anticholinergic effects (tachycardia, dry mouth, blurred vision) |
PPIs achieve deeper acid suppression than H2 blockers because they block the parietal cell's final common pathway (H+/K+-ATPase) regardless of what triggered it, while H2 blockers only interrupt one of the three convergent inputs — gastrin and vagal ACh still drive some acid output through the other two routes.
H. pylori Eradication Concept
Antiemetics
| Drug | Mechanism | Best Use |
|---|---|---|
| Ondansetron | 5-HT3 receptor antagonist | Chemotherapy- and postoperative-induced nausea; watch for QT prolongation |
| Metoclopramide | D2 antagonist, prokinetic | Diabetic gastroparesis; risk of extrapyramidal symptoms/tardive dyskinesia |
| Prochlorperazine | D2 antagonist | General nausea; extrapyramidal effects possible |
| Promethazine | Antihistamine (H1 blocker) with D2-antagonist activity | Motion sickness, migraine-associated nausea, allergy symptoms; sedation, anticholinergic effects |
| Scopolamine | Muscarinic antagonist | Motion sickness (transdermal patch); dry mouth, blurred vision |
| Aprepitant / fosaprepitant | NK1 (neurokinin-1/substance P) receptor antagonist | Add-on for chemotherapy-induced nausea; fatigue, GI upset |
These drugs sort by which afferent pathway they target rather than by drug class alone — 5-HT3 and D2 antagonists cover chemoreceptor trigger zone-driven nausea (chemo, postop, uremia), while H1/muscarinic antagonists cover vestibular-driven nausea (motion sickness) — so picking the right antiemetic depends on identifying the trigger, not just reaching for the strongest agent.
Octreotide
- Long-acting somatostatin analog — suppresses release of gastrin, VIP, and other splanchnic vasodilatory hormones, and reduces splanchnic blood flow
- Used for acute variceal bleeding, acromegaly, carcinoid syndrome, and VIPoma
- Adverse effects: nausea, cramping, steatorrhea; increases gallstone risk by inhibiting CCK-mediated gallbladder emptying
Antidiarrheals & IBD Therapeutics
- Loperamide and diphenoxylate: both are peripheral opioid-receptor agonists that slow gut motility; loperamide has essentially no CNS penetration (low abuse potential), while diphenoxylate is combined with atropine specifically to discourage misuse at high doses
- Sulfasalazine (sulfapyridine + 5-ASA): anti-inflammatory, activated by colonic bacteria; used in UC and Crohn colitis; adverse effects include reversible oligospermia and sulfonamide-related reactions
- Glucocorticoids (e.g., budesonide): induce remission in an IBD flare but are not used for long-term maintenance given their side-effect burden
- Azathioprine / 6-mercaptopurine: steroid-sparing immunomodulators for maintenance therapy in both Crohn disease and UC; bone marrow suppression is the main risk, worsened by concurrent allopurinol (both are metabolized by xanthine oxidase)
- Infliximab / adalimumab (anti-TNF monoclonal antibodies): used for moderate-to-severe Crohn disease and UC; screen for latent TB and hepatitis B before starting, since anti-TNF therapy can reactivate both
Laxative Classes
| Class | Example | Mechanism |
|---|---|---|
| Bulk-forming | Psyllium, methylcellulose | Adds fiber bulk, retains water in stool |
| Osmotic | Lactulose, magnesium citrate, polyethylene glycol | Draws water into the lumen; lactulose also traps ammonia (NH4⁺) — useful in hepatic encephalopathy |
| Stool softener | Docusate | Emulsifies stool, allows water/fat to penetrate |
| Stimulant | Senna, bisacodyl | Directly increases colonic motility/secretion |
| Hyperosmolar lubricant | Mineral oil | Draws water into the lumen and lubricates stool passage; can impair absorption of fat-soluble vitamins with prolonged use |
| Prokinetic | Metoclopramide | Increases upper GI motility and LES tone via D2 antagonism; useful in gastroparesis, does not primarily act on colonic transit |
| Chloride channel activator | Lubiprostone | Activates intestinal chloride channels to draw fluid into the lumen; used for chronic idiopathic constipation and constipation-predominant IBS |
| Guanylate cyclase-C agonist | Linaclotide, plecanatide | Raises intracellular cGMP → increases intestinal fluid/electrolyte secretion and speeds transit; also used for IBS with constipation |
| Serotonergic (5-HT4) agonist | Prucalopride | Stimulates enteric neurons to increase peristalsis; used for chronic idiopathic constipation |
| NHE3 inhibitor | Tenapanor | Blocks intestinal sodium/hydrogen exchange, reducing sodium absorption and drawing water into the lumen; used for IBS with constipation |
- Lactulose's benefit in hepatic encephalopathy comes from trapping ammonia as ammonium in the acidified colon — not simply from its laxative effect; rifaximin, a poorly absorbed antibiotic, complements this by directly reducing the population of ammonia-producing gut bacteria, and the two are often combined in refractory cases.
Orlistat
- Inhibits gastric and pancreatic lipase, blocking breakdown and absorption of dietary fat
- Used for weight loss, taken with fat-containing meals
- Adverse effects: abdominal cramping, flatulence, oily/frequent stools, and reduced absorption of fat-soluble vitamins
🧬 GI Embryology & Congenital Defects
Hirschsprung disease's aganglionic segment shares its exact mechanism — loss of myenteric (Auerbach) plexus neurons — with achalasia in the esophagus, discussed under Esophagus & Stomach — Disease → Esophageal Motility & Structural Disorders.
Foregut-Midgut-Hindgut Framework
- Foregut
- Distal esophagus → proximal duodenum (to major papilla)
- Liver, gallbladder, and ventral/dorsal pancreatic buds
- Arterial supply: celiac trunk
- Vagal (parasympathetic) + greater splanchnic (sympathetic) innervation
- Pancreatic bud fusion
- Ventral bud → pancreatic head (lower portion) and uncinate process; rotates dorsally to fuse with the dorsal bud
- Dorsal bud → body, tail, and most of the head
- Main pancreatic duct forms from fusion of the distal dorsal duct with the entire ventral duct; drains with the CBD at the major duodenal papilla
- Failed ventral bud rotation/fusion is the basis of annular pancreas
- Pancreas divisum: the dorsal and ventral ducts fail to fuse altogether, so drainage stays split between the minor papilla (dominant dorsal duct) and major papilla (ventral duct) — usually asymptomatic, but the most common congenital pancreatic anomaly and an occasional cause of pancreatitis
- Midgut
- Distal duodenum → proximal two-thirds of transverse colon
- Undergoes physiologic umbilical herniation (weeks 6–10), then 270° counterclockwise rotation around the SMA axis
- Arterial supply: superior mesenteric artery (SMA)
- Vagal + lesser splanchnic innervation
- Hindgut
- Distal one-third transverse colon → upper anal canal (above pectinate line)
- Arterial supply: inferior mesenteric artery (IMA)
- Pelvic splanchnic (parasympathetic, S2–S4) + lumbar splanchnic (sympathetic) innervation
- Anal canal transition at the pectinate line
- Above: hindgut-derived, columnar epithelium, visceral (dull) pain sensation
- Below: ectoderm-derived (proctodeum), squamous epithelium, somatic (sharp) pain sensation, internal vs external hemorrhoids split here
- Other ectoderm-derived GI structures
- Anterior two-thirds of the tongue, lips, parotid gland, and tooth enamel all derive from ectoderm (stomodeum) rather than foregut endoderm
Arterial supply, parasympathetic innervation, and embryologic origin all travel together along a single foregut-midgut-hindgut axis, so once you know which segment a structure derives from, you can predict its blood supply (celiac/SMA/IMA) and vagal-versus-pelvic parasympathetic input without memorizing them separately.
Tongue Development & Pharyngeal Arch Origins
- Anterior two-thirds of the tongue arises from arches 1–2 (taste via CN VII, general sensation via CN V3)
- Posterior one-third arises from arches 3–4 (taste and sensation mainly via CN IX, with CN X covering the extreme posterior)
- Mnemonic for taste/sensation split: CN VII and V3 cover the front, CN IX (and a little CN X) cover the back
- Nearly all tongue muscles are supplied by CN XII (motor), with the notable exception of palatoglossus (CN X)
- Genioglossus protrudes the tongue; styloglossus draws it up and back; hyoglossus depresses it
- Overall taste is carried by CN VII, IX, X; general/pain sensation by CN V3, IX, X; motor by CN X and XII
Digestive Tract Histology by Segment
| Segment | Epithelium / Distinguishing Features |
|---|---|
| Esophagus | Nonkeratinized stratified squamous; upper third is skeletal muscle, lower two-thirds smooth muscle, with a mixed transition zone in between |
| Stomach | Gastric pits/glands; eosinophilic (pink) parietal cells vs basophilic chief cells |
| Duodenum | Villi and microvilli maximize surface area; Brunner glands (submucosal, bicarbonate-secreting) are unique to this segment; crypts of Lieberkühn contain stem cells and Paneth cells (defensins, lysozyme) |
| Jejunum | Tallest, most numerous plicae circulares — creates a "feathery" look on contrast imaging; bulk of nutrient absorption occurs here |
| Ileum | Peyer patches (lymphoid follicles in lamina propria/submucosa) and the highest goblet cell density of the small bowel |
| Colon | Crypts of Lieberkühn packed with goblet cells, but no villi |
Each segment's distinguishing histologic feature exists because of what that segment does — Brunner glands neutralize acidic chyme entering the duodenum, Peyer patches in the ileum provide immune surveillance at the site of highest bacterial load, and the colon's villus-free, goblet-cell-dense crypts favor water/electrolyte absorption and mucus protection over nutrient uptake.
GI Tract Wall — Histologic Layers
- Submucosal (Meissner) plexus: primarily regulates secretion and local blood flow
- Myenteric (Auerbach) plexus: sits between the two muscle layers, primarily controls motility
- Loss of myenteric ganglion cells is the defect underlying both Hirschsprung disease (colon) and achalasia (esophagus)
Epiploic Foramen of Winslow
- Natural opening connecting the greater and lesser peritoneal sacs
- Anterior border: hepatoduodenal ligament (contains the common bile duct, proper hepatic artery, and portal vein — the "portal triad in miniature")
- Superior border: caudate lobe of the liver
- Inferior border: first part of the duodenum
- Posterior border: inferior vena cava
- Manually clamping the hepatoduodenal ligament (or applying a vascular clamp through the epiploic foramen) compresses the hepatic artery and portal vein, helping distinguish inflow bleeding from hepatic vein/IVC outflow bleeding during liver trauma or surgery
Key Peritoneal Ligaments
| Ligament | Connects | Carries |
|---|---|---|
| Falciform ligament | Liver to anterior abdominal wall | Ligamentum teres (remnant of fetal umbilical vein) |
| Hepatoduodenal ligament | Liver to duodenum | Portal triad; part of the lesser omentum; borders the epiploic foramen |
| Hepatogastric ligament | Liver to lesser curvature of stomach | Gastric vessels; part of the lesser omentum; separates the greater and lesser sacs on the right |
| Gastrocolic ligament | Greater curvature of stomach to transverse colon | Gastroepiploic vessels; part of the greater omentum |
| Gastrosplenic ligament | Greater curvature of stomach to spleen | Short gastric and left gastroepiploic vessels; separates the sacs on the left |
| Splenorenal ligament | Spleen to posterior abdominal wall | Splenic vessels and tail of pancreas |
Pectinate Line, Hemorrhoids & Anal Fissure
- The pectinate (dentate) line marks where hindgut endoderm meets ectoderm — it's the developmental hinge for how the anal canal is innervated, drained, and supplied
| Above the line | Below the line | |
|---|---|---|
| Embryologic origin | Hindgut (endoderm) | Proctodeum (ectoderm) |
| Epithelium | Columnar | Squamous |
| Arterial supply | Superior rectal artery (from IMA) | Inferior rectal artery (from internal pudendal artery) |
| Venous drainage | Superior rectal vein → IMV → portal system | Inferior rectal vein → internal pudendal vein → systemic (IVC) system |
| Innervation / pain | Visceral (inferior hypogastric plexus) — not painful | Somatic (pudendal nerve) — painful |
| Lymphatic drainage | Internal iliac nodes | Superficial inguinal nodes |
| Hemorrhoid type | Internal — painless, may bleed | External — painful, especially if thrombosed |
| Cancer type if malignant | Adenocarcinoma | Squamous cell carcinoma |
- Anal fissure: a tear in the anoderm below the pectinate line, classically in the posterior midline (the most poorly perfused area) — causes pain with defecation and bright red blood on the toilet paper; linked to constipation and low-fiber diets
Every column in this table — arterial supply, venous drainage, innervation, lymphatic drainage, and cancer type — is downstream of a single embryologic fact: what's above the line is hindgut endoderm and what's below is ectoderm, so knowing that one boundary predicts the whole clinical picture rather than requiring five separate memorized facts.
Arterial Watersheds & Vascular Compression Syndromes
- GI-supplying arteries branch off the aorta anteriorly and are unpaired (celiac, SMA, IMA); non-GI arteries (renal, gonadal, lumbar) branch laterally/posteriorly and are paired
- Two colonic "watershed" zones receive overlapping supply from the terminal branches of two different arteries, making them most vulnerable to ischemia during hypotension or embolism:
- Splenic flexure — junction of SMA and IMA territory
- Rectosigmoid junction — junction of the last sigmoid branch and the superior rectal artery (both IMA branches)
- Nutcracker syndrome: the left renal vein is compressed between the SMA and aorta → flank pain, hematuria, left-sided varicocele (in males) from backed-up renal venous pressure
- SMA syndrome: the third (transverse) part of the duodenum is compressed between the SMA and aorta, typically when mesenteric fat is diminished (rapid weight loss, malnutrition, post-bariatric surgery) → postprandial pain and intermittent obstruction
Abdominal Wall, Inguinal Canal & Hernias
- Hesselbach triangle is bordered by the inferior epigastric vessels (lateral), rectus abdominis (medial), and inguinal ligament (inferior) — it's the weak spot for direct hernias
- Spermatic cord layers, outside-in from the internal oblique/external oblique/transversalis fascia: external spermatic fascia, cremasteric muscle/fascia, internal spermatic fascia
| Hernia | Path | Relation to inferior epigastric vessels | Typical patient |
|---|---|---|---|
| Indirect inguinal | Through the deep (internal) inguinal ring, along the inguinal canal, out the superficial ring — follows the path of testicular descent | Lateral | Can present at any age; caused by a patent processus vaginalis, so more often congenital |
| Direct inguinal | Bulges directly through the abdominal wall within Hesselbach triangle, exiting only through the superficial ring | Medial | Older males, from acquired weakness of the transversalis fascia |
| Femoral | Below the inguinal ligament, through the femoral canal, medial to the femoral vein | — | More common in females; higher risk of incarceration/strangulation than inguinal hernias because the femoral canal is a rigid, narrow space |
- "MDs don't lie": Medial to the inferior epigastric vessels = Direct; Lateral = Indirect.
- Diaphragmatic/hiatal hernia: in infants, usually a congenital defect of the pleuroperitoneal membrane causing left-sided herniation into the thorax; in adults, laxity of the phrenoesophageal membrane allows the stomach to herniate through the esophageal hiatus (sliding type is far more common than paraesophageal, and is linked to GERD)
Rotation Errors & Clinical Correlates
- Incomplete rotation → malrotation, predisposes to midgut volvulus
- Failure of herniated gut to return → omphalocele (bowel covered by peritoneum/amnion)
- Failure of body wall closure (not a rotation defect) → gastroschisis (uncovered bowel, lateral to umbilicus)
Peritoneal Attachment Quick Reference
| Retroperitoneal (SAD PUCKER) | Intraperitoneal |
|---|---|
|
|
- Retroperitoneal structures are more prone to blunt trauma injury and typically lack a mesentery.
Congenital GI Malformations
| Condition | Mechanism | Clinical Clues |
|---|---|---|
| Hypertrophic pyloric stenosis | Hypertrophy of pyloric circular muscle | Non-bilious projectile vomiting at 2–8 weeks; palpable olive-shaped mass; firstborn males more affected |
| Duodenal atresia | Failure of duodenal lumen to recanalize | Bilious vomiting shortly after birth; "double bubble" on imaging; associated with Down syndrome |
| Jejunal/ileal atresia | Vascular accident in utero (disruption, not failure of recanalization) | "Apple peel" appearance; bilious vomiting |
| Annular pancreas | Ventral pancreatic bud fails to rotate properly, encircles duodenum | Duodenal obstruction, bilious vomiting |
| Meckel diverticulum | Persistent vitelline (omphalomesenteric) duct remnant; true diverticulum | Often asymptomatic; painless GI bleeding, intussusception, or volvulus in a child; typically located roughly 2 feet from the ileocecal valve and about 2 inches long; affects roughly 2% of the population, with males affected about twice as often; roughly half of symptomatic cases contain ectopic gastric or pancreatic tissue; diagnosed with a technetium-99m pertechnetate scan ("Meckel scan"), which picks up the ectopic gastric mucosa |
| Malrotation ± volvulus | Incomplete 270° rotation of midgut | Cecum mispositioned in upper abdomen; abnormal fixation predisposes to volvulus and bowel ischemia |
| Hirschsprung disease | Failure of neural crest cell migration → aganglionic segment (no Meissner/Auerbach plexuses) | Failure to pass meconium, distended abdomen, contracted distal segment with dilated proximal bowel; diagnosed by rectal biopsy |
| Anorectal malformations | Abnormal urorectal septum development | Imperforate anus; may communicate with urinary or vaginal tract as a fistula |
| Extrahepatic biliary atresia | Progressive fibro-obliteration of extrahepatic bile ducts | Persistent neonatal jaundice beyond 2 weeks, acholic stools, dark urine |
| Tracheoesophageal fistula | Abnormal septation of foregut into trachea and esophagus | Most common form: esophageal atresia with distal TEF; presents with choking/cyanosis with feeds, polyhydramnios in utero |
- Malrotation is a rotation defect (positional); intestinal atresia is a lumen/recanalization or vascular defect (structural) — both can obstruct, but the mechanism and imaging differ.